epiduo 0.1 % / 2.5 %
galderma nordic ab - adapalen / benzoylperoksid - gel - 0.1 % / 2.5 %
epiduo 0.3 % / 2.5 %
galderma nordic ab - adapalen / benzoylperoksid - gel - 0.3 % / 2.5 %
epiduo 0.1 % / 2.5 %
2care4 - adapalen / benzoylperoksid - gel - 0.1 % / 2.5 %
epiduo 0.1 % / 2.5 %
2care4 - adapalen / benzoylperoksid - gel - 0.1 % / 2.5 %
differin 1 mg/ g
galderma nordic ab - adapalen - gel - 1 mg/ g
differin 1 mg/ g
galderma nordic ab - adapalen - krem - 1 mg/ g
olysio
janssen-cilag international nv - simeprevir - hepatitt c, kronisk - antivirale midler til systemisk bruk - olysio er angitt i kombinasjon med andre legemidler til behandling av kronisk hepatitt c (chc) hos voksne pasienter. for hepatitt c-virus (hcv) genotypen bestemt aktivitet.
numient
amneal pharma europe ltd - levodopa, carbidopa - parkinsonsykdom - anti-parkinson medisiner - symptomatisk behandling av voksne pasienter med parkinsons sykdom.
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - mage-neoplasmer - antineoplastiske midler - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
prograf 0.5 mg
astellas pharma a/s - takrolimusmonohydrat - kapsel, hard - 0.5 mg